Do you want to read an article? Please log in or register.
Vaccination in adult patients with chronic lung diseases
Respiratory Tract Infection
RECOMMENDED
Related content
RECOMMENDED
COPDInterstitial Lung Disease
Pulmonary Rehabilitation and Functional Independence: Impact on Survival in Patients with Fibrotic Interstitial Lung Disease or Chronic Obstructive Pulmonary Disease
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Elmiger A, Marcin T, Bovet L, Brun P, Guler SA
doi: 10.1016/j.rmed.2024.107933
AsthmaCOPD
Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Curr Allergy Asthma Rep
Penders Y, Brusselle G, Falsey AR, Rohde G, Betancur E, Guardado ME, Agudelo JLR, Saeedi P, Harrington L, Michaud JP
doi: 10.1007/s11882-025-01194-w
COPDEmphysema
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS)
Respir Med
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM
doi: 10.1016/j.rmed.2024.107846
COMMENTED
Interstitial Lung Disease
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung diseaseDeveloped by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR)Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG)
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani B, Hoffmann-Vold AM
doi: 10.1183/13993003.02533-2024
Interstitial Lung Disease
Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: A systematic review and meta-analysis
Semin Arthritis Rheum
Zhang Q, McDermott GC, Juge PA, Chang SH, Vanni KM, Qian G, Bade KJ, Mueller KT, Kowalski EN, Saavedra AA, Sparks JA
doi: 10.1016/j.semarthrit.2024.152561
RECOMMENDED
Interstitial Lung Disease
Idiopathic inflammatory myopathies related lung disease in adults
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Alexander Turk, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Sehgal S, Patel A, Chatterjee S, Fernandez AP, Farver C, Yadav R, Li Y, Danoff SK, Saygin D, Huapaya JA, Wilfong EM, Highland KB
doi: 10.1016/S2213-2600(24)00267-4
RECOMMENDED
AsthmaCOPDInterstitial Lung Disease
Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Thorax
Whittaker H, Kramer Fiala Machado A, Hatam S, Cook S, Scully S, Evans HTT, Bolton T, Kallis C, Busby J, Heaney LG, Sheikh A, Quint JK, CVD-COVID-UK/COVID-IMPACT Consortium
doi: 10.1136/thorax-2024-222699
Interstitial Lung Disease
The impact of interstitial lung disease in patients with acid sphingomyelinase deficiency (ASMD) - A case series
Respir Med Case Rep
Costa I Colomer J, Garcia-Moyano M, Maiz L, Perez-Tarazona S, Ruiz de Valbuena M, Ceberio L, Correcher P, Juliá-Palacios N, Morales M, Pérez-Yagüe G, Villarrubia J, Pérez-Rojo R
doi: 10.1016/j.rmcr.2025.102202
Lung Cancer
Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitors
Clin Lung Cancer
Pinard L, Ullur AR, Everest L, Zhan LJ, Selvaratnam R, Balaratnam K, Khan K, Schmid S, Chotai S, Patel D, Al-Agha F, Grant B, Brown MC, Raptis R, Xu W, Moriarty P, Shepherd FA, Sacher AG, Leighl NB, Bradbury PA, Liu G, Kitchlu A
doi: 10.1016/j.cllc.2025.04.001